FDA responds to reports of antiviral rebound infections

With the rise of COVID-19 cases, antiviral medications are becoming prevalent such as Paxlovid. Health officials are now reporting antiviral rebound infections, where symptoms are developed or a test returns as positive days after the five day course of treatment.